OMS : l’espoir d’un consensus sur les contrefaçons reporté à l’Assemblée du mois de mai 29/01/2009 by Kaitlin Mara for Intellectual Property Watch Leave a Comment La semaine dernière, un rapport et un projet de résolution de l’Organisation mondiale de la santé (OMS) sur les produits médicaux contrefaits ont donné lieu à un débat animé, bien qu’aucun compromis n’ait encore été trouvé pour mettre fin aux désaccords quant au processus de consultation caché derrière le rapport sur les contrefaçons et au […]
Licensing Remains Essential But Elusive For Digital Music Providers 28/01/2009 by Monika Ermert for Intellectual Property Watch 1 Comment By Monika Ermert for Intellectual Property Watch CANNES – Giving licences to digital music providers has been on top of the agenda of the world’s largest music fair, Midem, and its technology forum Midemnet for about a decade now. But simple solutions still are not on the horizon and more and more governments are considering […]
WHO Global Strategy On IP And Health Considered, Implementation Advances 28/01/2009 by Kaitlin Mara for Intellectual Property Watch Leave a Comment By Kaitlin Mara Progress made on the World Health Organization strategy on public health and innovation was highlighted to WHO members on Saturday, including the production of a key budgeting document detailing timeframes and estimated costs of implementing the strategy. The Global Strategy and Plan of Action on Health, Innovation and Intellectual Property was discussed […]
Proposed EU Copyright Term Extension Faces Vocal Opposition In Parliament 27/01/2009 by David Cronin for Intellectual Property Watch 8 Comments By David Cronin for Intellectual Property Watch BRUSSELS – Strong opposition is being voiced by members of the European Parliament over plans to extend the copyright protection applying to sound recordings from 50 to 95 years. Both left and right-leaning Parliament members (MEPs) have signalled that they intend to vote against the proposed extension at […]
Hope For Consensus On WHO And Counterfeits Moves To May Assembly 27/01/2009 by Kaitlin Mara for Intellectual Property Watch 1 Comment By Kaitlin Mara A World Health Organization report and draft resolution on counterfeit medical products drew energetic debate last week, though no compromise has yet been found to bridge disagreements over the consultation process behind the counterfeit report and over the risk of confusing intellectual property violations with potentially dangerous misrepresentation of medicines. Members agreed […]
Potential Names For Obama IP Team Swirl; WTO IP Chief “Imminent” 27/01/2009 by Liza Porteus Viana, Intellectual Property Watch 1 Comment By Liza Porteus Viana for Intellectual Property Watch and William New Changes in several key international agencies and governments will bring a cadre of new faces to positions that address intellectual property policy, and some potential names for those spots have been circulating in recent weeks. The naming of the new chief of the World Trade Organization IP Division is “imminent,” according to sources close to the process. And as US President Barack Obama began his first weeks in office in late January, many IP-related positions also remain unfilled.
WTO Issues Final Decision On US-China Copyright Dispute 26/01/2009 by Kaitlin Mara for Intellectual Property Watch 5 Comments By Kaitlin Mara and William New China has been found in violation of two of its responsibilities under international rules on trade and intellectual property, and in partial violation of one more, said a World Trade Organization panel report on the US-China dispute over copyright and customs matters released Monday. But the panel did not […]
New International Pharma Industry Leader Brings Prospect Of Change 23/01/2009 by William New, Intellectual Property Watch 1 Comment By William New Alicia Greenidge represents a change for the global pharmaceutical and biotechnology industry, but as she grows into her role as the head of the industry’s international trade association, it is unclear whether there will be substantive changes on policy relating to intellectual property and public health. Key policy areas include counterfeit medicines and funding for research and development into diseases afflicting poor populations in ways that echo past industry approaches, but Greenidge brings a new focus on networking and negotiation.
WHO Puts Nearly $150 Billion Price Tag On Global R&D Strategy For Neglected Diseases 22/01/2009 by Kaitlin Mara for Intellectual Property Watch 2 Comments By Kaitlin Mara Estimated funding needs for the implementation of the World Health Organization strategy on global public health and intellectual property have been revealed in a new document. The document lays out element by element the expected cost of implementing the Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property […]
WHO Members Make Informal Progress On Plan Of Action As Executive Board Opens 20/01/2009 by Kaitlin Mara for Intellectual Property Watch Leave a Comment By Kaitlin Mara A small, diverse group of member states meeting informally over the weekend were able to resolve questions of which institutions should be actors in a broader plan of action for the implementation of the World Health Organization Global Strategy on Public Health, Innovation, and Intellectual Property, according to sources. The informal agreement […]